Medicare beneficiaries could see out-of-pocket prescription drug costs cut by more than half in 2026, according to a new AARP ...
According to healthcare research firm 3 Axis Advisors, drugmakers are planning to raise U.S. prices on medications including ...
The price hikes come even as the Trump administration pressures pharmaceutical companies to lower costs for patients and ...
The cost of medication was too high for thousands of CF sufferers around the world. Now a Bangladeshi company is making a generic version that will change lives ...
Three nonprofits committed up to $30 million to the creation of a low-cost drug manufacturer that was launched today by a group of hospital systems frustrated by drug shortages and escalating drug ...
Novo Nordisk Canada is considering competing with generic versions of its brand-name Ozempic and Wegovy drugs by introducing ...
Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including ...
In Canada, the patent for some semaglutide drugs has expired, paving the way for the country to become the first to offer ...